Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/100860
Título: | Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke | Autor: | Paiva, Luís Coelho, José Barra, Sérgio Costa, Marco Sargento-Freitas, João Cunha, Luís Gonçalves, Lino |
Palavras-chave: | Antiplatelet; Left atrial appendage; Occlusion; Oral anticoagulation | Data: | 2021 | Título da revista, periódico, livro ou evento: | Revista Portuguesa de Cardiologia | Volume: | 40 | Número: | 5 | Resumo: | Introduction: This study aimed to evaluate the performance of non-vitamin K antagonist oral anticoagulation (NOAC) in patients with previous stroke and non-valvular atrial fibrillation (AF) compared with left atrial appendage occlusion (LAAO) in primary and secondary stroke prevention settings. Methods: This was a prospective, single-center, non-randomized cohort study of 302 consecutive patients with non-valvular AF and at high risk for stroke. Two treatment strategies were compared: LAAO (n=91) and long-term treatment with NOAC (n=149). The primary outcome was the composite endpoint of death, stroke and major bleeding. Propensity score and cause-ofdeath analyses were performed to compare outcomes. Results: In a mean follow-up of 13 months, there were 30 deaths (LAAO 8.8% vs. NOAC 14.8%), five strokes (LAAO 1.1% vs. NOAC 2.7%) and six major bleeds (LAAO 1.1% vs. NOAC 3.4%). There was a non-significant trend for a lower incidence of the primary endpoint in the LAAO group (11.0% vs. 20.9%; HR 0.42, 95% CI 0.17-1.05, p=0.064). Considering only secondary prevention LAAO patients (34.1% of the LAAO group), there was also a non-significant lower incidence of the primary endpoint (LAAO 6.5% vs. 20.9%; HR 0.30, 95% CI 0.07-1.39, p=0.12). While about a fifth of LAAO patients stopped antiplatelet treatment six months after device implantation due to recurrent minor bleeding, no adverse cardiovascular event or major bleeding occurred in this subset of patients. | URI: | https://hdl.handle.net/10316/100860 | ISSN: | 08702551 | DOI: | 10.1016/j.repc.2020.07.021 | Direitos: | openAccess |
Aparece nas coleções: | FMUC Medicina - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
1-s2.0-S0870255121001062-main.pdf | 685.76 kB | Adobe PDF | Ver/Abrir |
Citações SCOPUSTM
3
Visto em 17/nov/2022
Citações WEB OF SCIENCETM
4
Visto em 15/nov/2022
Visualizações de página
100
Visto em 28/ago/2024
Downloads
54
Visto em 28/ago/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons